Snapshot from Jul 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / Regeneron securities fraud class action
Regulatory class action lawsuit

Regeneron securities fraud class action

Analysis based on 6 articles · First reported Jul 18, 2026 · Last updated Jul 21, 2026

Sentiment
-30
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The lawsuit may negatively impact Regeneron's stock price due to potential liability and reputational damage. However, the case is in early stages and market impact is likely limited until certification or further developments.

Pharmaceuticals
Event Summary

The The Schall Law Firm filed a class action lawsuit against Regeneron Pharmaceuticals for alleged securities fraud. The complaint claims Regeneron made false and misleading statements regarding its Phase III Fianlimab-Libtayo Study, using flawed statistical assumptions and failing to demonstrate clinical differentiation from other therapies. Investors who purchased Regeneron securities between August 1, 2025 and May 15, 2026 are affected. The class has not yet been certified.

Key Actions
70 The Schall Law Firm filed class action Regeneron Pharmaceuticals
Entities Involved
stock
Regeneron Pharmaceuticals
Regeneron is the defendant in a securities fraud class action lawsuit alleging misleading statements about its Phase III study. The company faces potential financial penalties and reputational harm.
Importance 100.0 Sentiment -40.0
priv
The Schall Law Firm
The Schall Law Firm is the plaintiff's law firm representing investors in the class action. The firm gains visibility and potential fees from the case.
Importance 30.0 Sentiment 10.0
govactor
United States — United States Securities and Exchange Commission
The SEC is referenced as the regulatory body under which the lawsuit is brought; no direct action by the SEC is involved.
Importance 20.0 Sentiment 0.0
per
Brian Schall
Brian Schall is the attorney at The Schall Law Firm handling the case; his role is to represent investors.
Importance 20.0 Sentiment 5.0
exch
Nasdaq
Nasdaq is the exchange where Regeneron is listed; the event has no direct impact on the exchange.
Importance 10.0 Sentiment 0.0
Relationships
The Schall Law Firm securities litigator ↔ United States — United States Securities and Exchange Commission The Schall Law Firm is a private law firm that specializes in filing securities class action lawsuits against public com
The Schall Law Firm related ↔ Brian Schall
United States — United States Securities and Exchange Commission related ↔ Brian Schall
United States — United States Securities and Exchange Commission related ↔ Nasdaq
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.